Effective April 1st, 2024, Stephen Cummings, CEO of Rizolve Partners, will step into the role of Interim CEO of Ontario Genomics (OG) on a part-time basis over the next six months. Under the direction of the OG Board of Directors and in close collaboration with company’s management team, Stephen will oversee OG’s strategic direction and support the Board in the recruitment process for the new President and CEO.
Stephen’s nine-year tenure on OG’s board, coupled with his background in strategic business advisory as CEO of Rizolve Partners and private equity/venture capital, uniquely positions him to guide OG through this transition period with a steady hand – whose mission is to lead the application of genomics-based solutions across key sectors of the economy to drive economic growth, improved quality of life and global leadership for Ontario.
We look forward to embarking on this journey together with Ontario Genomics.